Your browser doesn't support javascript.
loading
Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status.
Aldoss, Ibrahim; Pham, Anh; Li, Sierra Min; Gendzekhadze, Ketevan; Afkhami, Michelle; Telatar, Milhan; Hong, Hao; Padeganeh, Abbas; Bedell, Victoria; Cao, Thai; Khaled, Samer K; Malki, Monzr M Al; Salhotra, Amandeep; Ali, Haris; Aribi, Ahmed; Palmer, Joycelynne; Aoun, Patricia; Spielberger, Ricardo; Stein, Anthony S; Snyder, David; O'Donnell, Margaret R; Murata-Collins, Joyce; Senitzer, David; Weisenburger, Dennis; Forman, Stephen J; Pullarkat, Vinod; Marcucci, Guido; Pillai, Raju; Nakamura, Ryotaro.
Afiliação
  • Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Pham A; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Li SM; Department of Information Sciences, Division of Biostatistics, City of Hope, Duarte, CA, USA.
  • Gendzekhadze K; HLA Laboratory, City of Hope, Duarte, CA, USA.
  • Afkhami M; Department of Pathology, City of Hope, Duarte, CA, USA.
  • Telatar M; Department of Pathology, City of Hope, Duarte, CA, USA.
  • Hong H; Department of Pathology, City of Hope, Duarte, CA, USA.
  • Padeganeh A; Department of Cytogenetics, City of Hope, Duarte, CA, USA.
  • Bedell V; Department of Cytogenetics, City of Hope, Duarte, CA, USA.
  • Cao T; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Khaled SK; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Malki MMA; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Salhotra A; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Ali H; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Aribi A; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Palmer J; Department of Information Sciences, Division of Biostatistics, City of Hope, Duarte, CA, USA.
  • Aoun P; Department of Pathology, City of Hope, Duarte, CA, USA.
  • Spielberger R; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Stein AS; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Snyder D; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • O'Donnell MR; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Murata-Collins J; Department of Cytogenetics, City of Hope, Duarte, CA, USA.
  • Senitzer D; HLA Laboratory, City of Hope, Duarte, CA, USA.
  • Weisenburger D; Department of Pathology, City of Hope, Duarte, CA, USA.
  • Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
  • Pillai R; Department of Pathology, City of Hope, Duarte, CA, USA.
  • Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA rnakamura@coh.org.
Haematologica ; 102(12): 2030-2038, 2017 12.
Article em En | MEDLINE | ID: mdl-28971906
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Proteína Supressora de Tumor p53 / Transplante de Células-Tronco Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Proteína Supressora de Tumor p53 / Transplante de Células-Tronco Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article